中信里昂:予中芯國際(0981.HK)“沽售”評級 目標價11港元
中芯國際(0981.HK)承認美國製裁帶來原材料方面的影響。中信里昂發表研究報告指消息負面,但相信制裁嚴重程度似乎較實體清單少,估計制裁或適用於先進技術應用(14nm以下),料其他半導體晶圓代工廠轉單得益,未如預期,繼續建議“沽售”中芯,目標價為11港元。
中信里昂相信,中國對美方向中芯施予制裁的容忍程度,將較制裁華為低,擔心中方會有報復行動,令中美貿易摩擦進一步升級,估計行業風險會增加,呼籲投資者要轉為防守。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.